Delivery Order SPE2DB24D2101-SPE2DB25FKMNQ
- Not listed
- The Defense Logistics Agency awarded a $13,259.50 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Scemblix 40 mg tablets in quantities of 60 units. This firm fixed-price, competitively awarded contract with no set-aside designation is scheduled for completion by August 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Scemblix is a prescription medication used in the treatment of chronic myeloid...
- This is a $26,519.00 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SCEMBLIX 40 MG TABLET, a pharmaceutical product, with a performance period ending on July 28, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This is a $39,778.50 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SCEMBLIX 40 MG TABLET UU 60S, a pharmaceutical product. The contract has an ultimate completion date of July 3, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,519.00, is a delivery order for the medication SCEMBLIX 40 MG TABLET, with a performance period extending through May 7, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and has no listed...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $12,646.91 firm fixed-price delivery order is for pharmaceutical product SCEMBLIX 20 MG TABLET UU 60S, with a completion date of January 15, 2025. Amerisourcebergen is a major pharmaceutical distributor that is a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The award is not associated with a set-aside...
- This is a $26,519.00 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568461040 - SCEMBLIX 40 MG TABLET UU 60S, a prescription medication, with a completion date of June 27, 2025. The contract is not set-aside and was awarded on June 5, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,259.50, is for the delivery of SCEMBLIX 40 MG TABLET medication, with a performance period through May 7, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor, and the place of performance is...
- This federal contract award, valued at $13,259.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SCEMBLIX 40 MG TABLET UU 60S, a pharmaceutical product, and is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corporation holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SCEMBLIX 40 MG TABLET in quantities of 60s, with a firm fixed price of $13,259.50 and a completion date of June 6, 2025. The contract is not set aside and is part of Amerisourcebergen Drug Corp's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,259.50, is for the delivery of SCEMBLIX 40 MG TABLET UU 60S, a pharmaceutical product. The contract is a firm fixed-price arrangement with a period of performance through July 24, 2025. It is not designated as a set-aside contract, indicating open competition....
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKMNQDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,637.88 to AmerisourceBergen Drug Corp for the supply of Scemblix 20 mg tablets (60-count units) under a firm fixed-price contract type. The award, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, represents a non-competitive delivery against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug Corp's comprehensive prime IDC with DLA valued at $999,999,999.00 and extending through December 2026, which serves as a global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies a broad range of pharmaceutical products, medical devices, and specialized healthcare commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Scemblix order supports DLA's medical supply chain requirements for neurological and specialty pharmaceutical treatment needs within the federal military healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.6k | 7/21/25 |